- Report
- January 2019
- 212 Pages
Global
From €21145EUR$22,000USD£18,133GBP
Boniva is a brand name for ibandronate sodium, a bisphosphonate drug used to treat and prevent osteoporosis in postmenopausal women. It is part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat conditions such as diabetes, thyroid disorders, and obesity. Boniva works by slowing down the rate of bone breakdown, which helps to reduce the risk of fractures. It is typically taken once a month, either orally or intravenously.
Boniva is manufactured by several companies, including GlaxoSmithKline, Teva Pharmaceuticals, and Mylan. It is available in both generic and brand name forms. Other bisphosphonates, such as Fosamax and Actonel, are also available in the Endocrine and Metabolic Disorders Drugs market. Show Less Read more